SANGAMO THERAPEUTICS, INC (SGMOQ) Form 10-K Annual Reports
SANGAMO THERAPEUTICS, INC (SGMOQ) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SGMOQ
CIK: 1001233
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerOren Lang-Furr
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-14 | 8-K | 0001193125-26-423054 | View SEC Doc Filr Page |
| 25-NSE | 2026-10-07 | — | 25-NSE Filing | 0001354457-26-000959 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-17 | 8-K | 0001193125-26-396644 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-02 | FORM 8-K | 0001104659-26-105905 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-25 | 8-K | 0001193125-26-374328 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-17 | 2026-06-30 | NT 10-Q | 0001193125-26-354282 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003615 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-12 | 8-K | 0001193125-26-347524 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-06 | 8-K | 0001193125-26-346796 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-14 | 8-K | 0001193125-26-309012 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-24 | 8-K | 0001193125-26-292501 | View SEC Doc Filr Page |
| 8-K/A | 2026-06-23 | 2026-06-18 | 8-K/A | 0001193125-26-279630 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-18 | 8-K | 0001193125-26-278582 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-25 | 4 Filing | 0002041855-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-25 | 4 Filing | 0002089213-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-25 | 4 Filing | 0001947007-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-25 | 4 Filing | 0001877368-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-25 | 4 Filing | 0001675687-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002166 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001628280-26-035067 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001628280-26-035061 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001628280-26-028524 | View SEC Doc Filr Page |
| 8-K | 2026-04-29 | 2026-04-28 | 8-K | 0001628280-26-028128 | View SEC Doc Filr Page |
| 4 | 2026-04-23 | 2026-04-22 | 4 Filing | 0002041855-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-04-23 | 2026-04-21 | 4 Filing | 0001947007-26-000010 | View SEC Doc Filr Page |